Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Dec 15, 2022 6:39pm
96 Views
Post# 35174594

RE:RE:RE:RE:RE:RE:RE:RE:RE:DrDR

RE:RE:RE:RE:RE:RE:RE:RE:RE:DrDRCraig, If you have questions about anything I told you five years ago, get the BCSC to ask me.

I have never once known anything about, or said anything about, a thousand mice. 

That's hilarious. I know, people in the industry know, and most of God's children know that a few dozen mice, maybe, that's all. I've never known of anything Bioasis planned or did that involved so many mice, not even a tenth that many. Looking back, I don't think I've known about any mouse study before it was made public. I knew that Scarpa intended to do studies, but so did everybody else. Those studies were long over before I was told the results, mostly because there was a problem with the studies. Some or all of the mouse tissues were thrown out or something like that, requiring some work to be done again so that Bioasis could make a reliable LSD pitch to a major pharma, whose name you know.

You sure you're not thinking of the Pied Piper of Hamelin?

That's embarrassing to raise a number like that. A thousand mice!

jd
<< Previous
Bullboard Posts
Next >>